Mika Derynck

Mika Derynck has extensive work experience in the medical field, with key roles at prominent organizations. From 1991 to 1994, they worked as an Internal Medicine Resident at Johns Hopkins Hospital. Following that, they joined UCSF Medical Center and held roles as an Oncology Fellow and Assistant Clinical Professor from 1994 to 2003. In 2004, Derynck started their tenure at Genentech, where they served as a Senior Group Medical Director until 2019. In April 2019, they became the Chief Medical Officer at Amunix.

Mika Derynck completed a Doctor of Medicine (MD) degree at the Boston University School of Medicine. Following that, from 1991 to 1994, they pursued an Internal Medicine Residency at the Johns Hopkins Hospital. They then concluded their education by undertaking a Fellowship in Medical Oncology at the University of California, San Francisco, from 1994 to 1997. No specific field of study was mentioned for any of these degrees or programs.